Editas Medicine (NQ: EDIT )
3.870
+0.080
(+2.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Editas Medicine
![](https://cdn.benzinga.com/files/images/story/2024/08/08/Dati-deludenti-sulloccupazione-USA-e-i-m.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_a_1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Unveiling 5 Analyst Insights On Editas Medicine
June 18, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For Editas Medicine
February 29, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600gene.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2021/09/undervalued-stocks.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/776607/person-in-a-lab-looking-through-a-microscope.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/768106/three-investors-look-at-papers.jpg)
![](https://g.foolcdn.com/editorial/images/767454/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://g.foolcdn.com/editorial/images/767772/scientist-injecting-samples-into-test-tubes.jpg)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-biotech-011-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/28/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/28/advance_auto_parts_-_logo.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.